Related Experiment Video

Updated: Oct 6, 2025

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx
06:37

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster using CRISPR/CasRx

Published on: February 5, 2021

3.2K

CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?

Diana Perez-SanJose1,2, Miguel Angel de la Fuente2,3, Julia Serna Pérez2,4

  • 1National Influenza Center of Valladolid, Hospital Clínico Universitario de Valladolid, University of Valladolid, 47010 Valladolid, Spain.

Pharmaceuticals (Basel, Switzerland)
|January 21, 2022
PubMed

Insights

This study demonstrates the effectiveness of the CRISPR/CasRx system in degrading messenger RNA (mRNA) for potential antiviral applications against influenza and other RNA viruses. The CRISPR/CasRx tool significantly reduced reporter gene expression, showing promise for new antiviral strategies.

Area of Science:

  • Virology
  • Molecular Biology
  • Biotechnology

Background:

  • Influenza viruses pose a significant global health threat due to their high transmissibility and potential for severe complications.
  • Existing antiviral treatments for influenza are limited and face challenges with emerging drug resistance.
  • Novel antiviral strategies are crucial to combat influenza and other RNA viruses.

Purpose of the Study:

  • To evaluate the efficacy of the CRISPR/CasRx system as a potential antiviral agent against RNA viruses.
  • To demonstrate the CasRx endonuclease's capability in degrading target mRNA.
  • To optimize conditions for the CRISPR/CasRx system's performance.

Main Methods:

  • Proof-of-concept study utilizing the CRISPR/CasRx system.
  • Verification of CasRx endonuclease activity on eGFP mRNA reporter gene.
  • Assessment of system performance using fluorescence microscopy, flow cytometry, and qRT-PCR.

Main Results:

  • Significant reduction in fluorescence indicating successful mRNA degradation.
  • Flow cytometry showed an 86-90% decrease in fluorescence.
  • qRT-PCR confirmed a 51-80% reduction in mRNA expression levels.

Conclusions:

  • The CasRx endonuclease is an effective tool for targeted mRNA knockdown.
  • The CRISPR/CasRx system shows promise as a novel antiviral strategy.
  • Further research is warranted to develop CRISPR/CasRx into a viable antiviral therapy.
Keywords:
CRISPR/Cas systemCRISPR/Cas13dCRISPR/CasRxantiviralinfluenza virus

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

722
Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection11:28

Designing, Packaging, and Delivery of High Titer CRISPR Retro and Lentiviruses via Stereotaxic Injection

Published on: May 23, 2016

17.8K

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.3K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
535
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.6K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.6K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
194